Only One of These Stocks Won’t Be a Winner: LDK Solar Co., Ltd (ADR) (LDK), Navidea Biopharmaceuticals Inc (NAVB) and More

But other solar shops might face more dire circumstances sooner than LDK, as the Fool’s Travis Hoium points out JA Solar Holdings Co., Ltd. (ADR) (NASDAQ:JASO) has bonds due in May and Trina Solar Limited (ADR) (NYSE:TSL) follows in July. Not every solar company is on the brink of folding financially, of course, and because the U.S. market looks healthier these days — new solar electric capacity increased 76% last year according to one research house — the damage has been fairly limited. Heck, Trina even rose yesterday by more than 3%. But I’m convinced we’ll see more companies go under or else they’ll be acquired by their peers. The solar power industry is going to look a lot different this time next year.

Thank you, sir. May I have another?!
Well, that’s just silly. Biotech Navidea Biopharmaceuticals Inc (NYSEAMEX:NAVB) got FDA approval for Lymphoseek everyone was expecting and its stock is now down 15% since the news was announced. My Foolish colleague and biotech guru Brian Orelli says it’s simply suffering from a case of “sell the news.”

Last week I said short sellers might have a point in that a lot of anticipation was built into the stock because the market opportunity for the lymphatic system cancer marker is less than what it appears. The total market may be around $450 million, but because Navidea Biopharmaceuticals Inc (NYSEAMEX:NAVB) is splitting the proceeds in the U.S. evenly with Cardinal Health, Inc. (NYSE:CAH), the amount realized will be a lot less.

Of course, there’s still the European market, where it’s also filed for approval, and I’m just as confident it will win the nod there as it did here. We’ll see a turnaround in Navidea Biopharmaceuticals Inc (NYSEAMEX:NAVB)’s stock sooner rather than later, which is why I don’t plan on closing out my outperform rating on the biotech on Motley Fool CAPS. I made that call last week and, though the stock has sunk since then, I’m looking forward to the inevitable rebound.

The article Only One of These Stocks Won’t Be a Winner originally appeared on Fool.com.

Fool contributor Rich Duprey owns shares of Apple and Cisco Systems (NASDAQ:CSCO). The Motley Fool recommends Apple and Cisco Systems. It also owns shares of Apple and Microsoft.

Copyright © 1995 – 2013 The Motley Fool, LLC. All rights reserved. The Motley Fool has a disclosure policy.